A recent judgment of the European Court of Justice in the Hanner case 1 has important consequences also for Slovenian legislation.
In short, in the Hanner case, Swedish law on the marketing of medicines was examined. Under Swedish national law, retail trade in non-prescription and prescription medicinal preparations can be engaged in only by the State or by legal persons over which the State has a dominant influence. Since 1970, the Swedish government has entrusted retail trade in medicinal preparations to Apoteket, a mainly non-profit company, managed by politicians and State civil servants. The Swedish authorities commenced criminal proceedings against the general manager of Bringwell International AB, Krister Hanner, for marketing products regarded as non-prescription medicinal preparations. In his defense, Mr Hanner contended that Swedish national law was contrary to Articles 28, 31 and 43 of the Treaty of the European Community (henceforth 'EC'), which deal with the existence of State monopolies. In its judgment of 31 May 2005 the Court held that the system of selecting medicines operated by Apoteket was liable to place medicines from other Member States at a disadvantage compared with trade in Swedish medicines. As such the Swedish system was contrary to EC competition law.
Despite the fact that Swedish regulation on retail trade of medicines is very specific in Europe, Slovenian law on the purchase and distribution of pharmaceuticals entails certain rules, which must in future be considered in view of the Hanner judgment and background case law on free movement of goods.
In this regard, this article analyses Slovenian regulations regarding distribution of immunological medicinal products, their consistency with the wider national legal system and emphasises those aspects that might be inconsistent with the rules of the EC internal market.
I. Immune prophylaxis and chemoprophylaxis in Slovenia
Immune prophylaxis (vaccination) and chemoprophylaxis (protection with medicines) in Slovenia are carried out according to the regulated programmes for specific groups of inhabitants. Vaccination is carried out not only by doctors in public health institutes and in the private sector but also by the Slovenian Institute of Public Health. Their work is harmonised by the coordinators of the Regional Institutes of Public Health and the national coordinator of the Institute of Public Health (henceforth 'the Institute'). According to the annual programme of immune prophylaxis and chemoprophylaxis, issued by the Minister for Health, immune prophylaxis and chemoprophylaxis are performed exclusively using preparations which are purchased, quality controlled and distributed by the Institute.
The exclusive right of the Institute to purchase and distribute the vaccines and other pharmaceuticals for immune prophylaxis and chemoprophylaxis certainly restricts the freedom of economic initiative, which is granted by the Slovenian Constitution and represents a form of legally regulated State monopoly. This monopoly prevents private legal persons from purchasing and distributing immunological medicinal products and hence abolishes competition in this field.
The fact that Slovenia, together with nine other States, acceded to the European Union in 2004 gives the question of exclusive rights another perspective, since these special rights may hinder one of fundamental freedoms of the internal market -the free movement of goods.
II. Legal status and competencies of the Slovenian Institute of Public Health
The Institute was established by the Slovene Government's Decree of 17 December 1992 in the statutory form of a public institute. The Slovenian Institutes Act states that public institutes should be established for performance of public services. Permanent and undisturbed performance of public services is assured by the State or local government for public interest reasons.
